CDKN2C antibody (AA 101-168) (Cy5)
Quick Overview for CDKN2C antibody (AA 101-168) (Cy5) (ABIN706185)
Target
See all CDKN2C AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 101-168
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CDKN2C
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))
-
Alternative Name
- CDKN2C
-
Background
-
Synonyms: CDK6 inhibitor p18, CDKN 2C, CDKN 6, CDKN2C, CDKN6, CDN2C_HUMAN, Cyclin dependent inhibitor, Cyclin dependent kinase 4 inhibitor C, Cyclin dependent kinase 6 inhibitor, Cyclin dependent kinase 6 inhibitor p18, Cyclin dependent kinase inhibitor 2C p18 inhibits CDK4, Cyclin dependent kinase inhibitor 2C, Cyclin-dependent kinase 4 inhibitor C, Cyclin-dependent kinase 6 inhibitor, INK4C, OTTHUMP00000046546, p18, p18 inhibits CDK4, p18 INK4C, p18 INK6, p18-INK4C, p18-INK6.
Background: p18 INK4C is a specific inhibitor of cdk4 / cdk6 (it interacts strongly with CDK6 and weakly with CDK4), and is expressed during G1 to S transition in the eukaryotic cell division cycle. It is maximally induced as cells enter S phase. Highest expression levels are found in skeletal muscle, but it is also found in the pancreas and heart.
-
Gene ID
- 1031
-
Pathways
- Cell Division Cycle, Mitotic G1-G1/S Phases
Target
-